SPT-2101

N/A

Report date: 2026/01/07 17:59:48

Base Information

Drug NameSPT-2101
Drug Alias Name6% dexamethasone地塞米松缓释制剂dexamethasone suspension6% dexamethasone formulated for sustained releaseSPT-2101 +[6] 
ClassificationSmall molecules > Steroids
Mechanisms of ActionGlucocorticoid receptor agonists
TargetsGlucocorticoid receptor
Therapy Area/IndicationsMeniere Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryAustralia
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesSpiral Therapeutics Australia Pty Ltd
China Registration ClassN/A

Develop Information

Active CompaniesSpiral Therapeutics Australia Pty Ltd
Inactive CompaniesN/A
Active IndicationsMeniere Disease
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A